Stockreport

MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance [Yahoo! Finance]

MaxCyte, Inc.  (MXCT) 
PDF technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics, today announced its financial results for the third quart [Read more]